Small Airways Response to Bronchodilators in Adults with Asthma or COPD: A Systematic Review

References

• Chhabra SK. Test of reversibility of airway obstruction: time for a review? Editorial. Lung India. 2013;30(1):3–4. doi:10.4103/0970-2113.106118
   PubMedGoogle Scholar
• Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70–e88. doi:10.1164/rccm.201908-1590ST
   PubMed Web of Science ®Google Scholar
• Higham A, Quinn AM, Cancado JED, Singh D. The pathology of small airways disease in COPD: historical aspects and future directions. Respir Res. 2019;20(1):49. doi:10.1186/s12931-019-1017-y
   PubMed Web of Science ®Google Scholar
• Usmani OS, Singh D, Spinola M, Bizzi A, Barnes PJ. The prevalence of small airways disease in adult asthma: a systematic literature review. Respir Med. 2016;116:19–27. doi:10.1016/j.rmed.2016.05.006
   PubMed Web of Science ®Google Scholar
• BTS/SIGN. British guideline on the management of asthma. Available from: https://www.brit-thoracic.org.uk/quality-improvement/guidelines/asthma/. Accessed October 30, 2020.
   Google Scholar
• Quanjer PH, Weiner DJ, Pretto JJ, Brazzale DJ, Boros PW. Measurement of FEF25–75% and FEF75% does not contribute to clinical decision making. Eur Respir J. 2014;43(4):1051–1058. doi:10.1183/09031936.00128113
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319. doi:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Coates AL, Allen PD, MacNeish CF, Ho SL, Lands LC. Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis. Chest. 2001;119(4):1123–1130. doi:10.1378/chest.119.4.1123
   PubMed Web of Science ®Google Scholar
• Newhouse MT. Asthma therapy with aerosols: are nebulizers obsolete? A continuing controversy. J Pediatr. 1999;135(1):5–8. doi:10.1016/s0022-3476(99)70317-3
   PubMed Web of Science ®Google Scholar
• Molimard M, Bourcereau J, Le Gros V, Bourdeix I. Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD. Respir Med. 2005;99(6):695–702. doi:10.1016/j.rmed.2004.11.009
   PubMed Web of Science ®Google Scholar
• Calverley PMA, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax. 2003;58(8):659. doi:10.1136/thorax.58.8.659
   PubMed Web of Science ®Google Scholar
• National Institute for Health Care Excellence (NICE). Diagnosis: Bronchodilator Reversibility. National Institute for Health and Care Excellence (UK); 2017.
   Google Scholar
• Tweeddale PM, Alexander F, McHardy GJ. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax. 1987;42(7):487–490. doi:10.1136/thx.42.7.487
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968. doi:10.1183/09031936.05.00035205
   PubMed Web of Science ®Google Scholar
• British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax. 1997;52(Suppl 5):S1–S28. doi:10.1136/thx.52.2008.S1.5
   PubMed Web of Science ®Google Scholar
• Chhabra SK. Acute bronchodilator response has limited value in differentiating bronchial asthma from COPD. J Asthma. 2005;42(5):367–372. doi:10.1081/JAS-62992
   PubMed Web of Science ®Google Scholar
• Janson C, Malinovschi A, Amaral AFS, et al. Bronchodilator reversibility in asthma and COPD: findings from three large population studies. Eur Respir J. 2019;54:1900561. doi:10.1183/13993003.00561-2019
   PubMed Web of Science ®Google Scholar
• Albert P, Agusti A, Edwards L, et al. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Thorax. 2012;67(8):701. doi:10.1136/thoraxjnl-2011-201458
   PubMed Web of Science ®Google Scholar
• Tan WC, Vollmer WM, Lamprecht B, et al. Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study. Thorax. 2012;67(8):718–726. doi:10.1136/thoraxjnl-2011-201445
   PubMed Web of Science ®Google Scholar
• Denlinger LC, Phillips BR, Ramratnam S, et al. Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations. Am J Respir Crit Care Med. 2017;195(3):302–313. doi:10.1164/rccm.201602-0419OC
   PubMed Web of Science ®Google Scholar
• Galant SP, Morphew T, Newcomb RL, Hioe K, Guijon O, Liao O. The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometry. J Pediatr. 2011;158(6):953–959 e1. doi:10.1016/j.jpeds.2010.11.029
   PubMed Web of Science ®Google Scholar
• Almeshari MA, Alobaidi NY, Edgar RG, Stockley J, Sapey E. Physiological tests of small airways function in diagnosing asthma: a systematic review. BMJ Open Respir Res. 2020;7(1):e000770. doi:10.1136/bmjresp-2020-000770
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(5):770–777. doi:10.1164/ajrccm.164.5.2012122
   PubMed Web of Science ®Google Scholar
• Schermer T, Heijdra Y, Zadel S, et al. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD. Respir Med. 2007;101(6):1355–1362. doi:10.1016/j.rmed.2006.09.024
   PubMed Web of Science ®Google Scholar
• Wouters EFM, Verschoof AC, Polko AH, Visser BF. Impedance measurements of the respiratory system before and after salbutamol in COPD patients. Respir Med. 1989;83(4):309–313. doi:10.1016/S0954-6111(89)80202-1
   PubMed Web of Science ®Google Scholar
• Borrill ZL, Houghton CM, Woodcock AA, Vestbo J, Singh D. Measuring bronchodilation in COPD clinical trials. Br J Clin Pharmacol. 2005;59(4):379–384. doi:10.1111/j.1365-2125.2004.02261.x
   PubMed Web of Science ®Google Scholar
• Bosken CH, Wiggs BR, Paré PD, Hogg JC. Small airway dimensions in smokers with obstruction to airflow. Am Rev Respir Dis. 1990;142(3):563–570. doi:10.1164/ajrccm/142.3.563
   PubMedGoogle Scholar
• Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278(25):1355–1360. doi:10.1056/nejm196806202782501
   PubMed Web of Science ®Google Scholar
• Stockley JA, Ismail AM, Hughes SM, Edgar R, Stockley RA, Sapey E. Maximal mid-expiratory flow detects early lung disease in alpha1-antitrypsin deficiency. Eur Respir J. 2017;49(3):1602055. doi:10.1183/13993003.02055-2016
   PubMed Web of Science ®Google Scholar
• Papi A, Vestbo J, Fabbri L, et al. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. Lancet. 2018;391(10125):1076–1084. doi:10.1016/S0140-6736(18)30206-X
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi:10.1136/bmj.b2700
   PubMed Web of Science ®Google Scholar
• Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi:10.1186/s13643-016-0384-4
   PubMedGoogle Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi:10.1136/bmj.l4898
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood institute. Study quality assessment tools. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed October 19, 2021.
   Google Scholar
• El-Khatib MF, Jamaleddine G, Kanj N, et al. Effect of heliox- and air-driven nebulized bronchodilator therapy on lung function in patients with asthma. Lung. 2014;192(3):377–383. doi:10.1007/s00408-014-9570-0
   PubMed Web of Science ®Google Scholar
• Fakharian A, Fahimi F, Salamzadeh J, Mohammadi M, Masjedi MR. Spirometric improvements with two commonly used spacers in asthmatic patients. Tanaffos. 2008;7(3):37–40.
   Google Scholar
• Lipworth BJ, Clark DJ. Effects of airway calibre on lung delivery of nebulised salbutamol. Thorax. 1997;52(12):1036–1039. doi:10.1136/thx.52.12.1036
   PubMed Web of Science ®Google Scholar
• Mariotta S, Sposato B, Ricci A, Bruno P, Aquilini M, Mannino F. Reversibility test in the early stages of bronchial asthma. J Asthma. 2005;42(6):487–491. doi:10.1081/JAS-67536
   PubMed Web of Science ®Google Scholar
• Nair A, Ward J, Lipworth BJ. Comparison of bronchodilator response in patients with asthma and healthy subjects using spirometry and oscillometry. Ann Allerg Asthma Immunol. 2011;107(4):317–322. doi:10.1016/j.anai.2011.07.011
   PubMed Web of Science ®Google Scholar
• Ohwada A, Inami K, Onuma E, Matsumoto-Yamazaki M, Atsuta R, Takahashi K. Bronchial reversibility with a short-acting beta2-agonist predicts the FEV1 response to administration of a long-acting beta2-agonist with inhaled corticosteroids in patients with bronchial asthma. Exp Ther Med. 2011;2(4):619–623. doi:10.3892/etm.2011.268
   PubMed Web of Science ®Google Scholar
• Rajkumar VHK, Gaur SN. Comparative evaluation of market spacer and home made spacer in the management of bronchial asthma. J Assoc Phys India. 2002;50:397–399.
   PubMedGoogle Scholar
• Schecker MH, Wilson AF, Mukai DS, Hahn M, Crook D, Novey HS. A device for overcoming discoordination with metered-dose inhalers. J Allerg Clin Immunol. 1993;92(6):783–789. doi:10.1016/0091-6749(93)90054-j
   PubMed Web of Science ®Google Scholar
• Tavares e Castro A, Matos P, Tavares B, Matos MJ, Segorbe-Luis A. Alternative functional criteria to assess airflow-limitation reversibility in asthma. Rev Port Pneumol. 2015;21(2):69–75. doi:10.1016/j.rppnen.2014.08.002
   PubMedGoogle Scholar
• Yaegashi M, Yalamanchili VA, Kaza V, Weedon J, Heurich AE, Akerman MJ. The utility of the forced oscillation technique in assessing bronchodilator responsiveness in patients with asthma. Respir Med. 2007;101(5):995–1000. doi:10.1016/j.rmed.2006.09.001
   PubMed Web of Science ®Google Scholar
• Park JH, Lee JH, Kim HJ, et al. Usefulness of impulse oscillometry for the assessment of bronchodilator response in elderly patients with chronic obstructive airway disease. J Thorac Dis. 2019;11(4):1485–1494. doi:10.21037/jtd.2019.03.34
   PubMed Web of Science ®Google Scholar
• Sylvester KP, Clayton N, Cliff I, et al. ARTP statement on pulmonary function testing 2020. BMJ Open Respir Res. 2020;7(1):e000575. doi:10.1136/bmjresp-2020-000575
   PubMed Web of Science ®Google Scholar
• Kesten S, Rebuck AS. Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD? Chest. 1994;105(4):1042–1045. doi:10.1378/chest.105.4.1042
   PubMed Web of Science ®Google Scholar
• Han MK, Wise R, Mumford J, et al. Prevalence and clinical correlates of bronchoreversibility in severe emphysema. Eur Respir J. 2010;35(5):1048. doi:10.1183/09031936.00052509
   PubMed Web of Science ®Google Scholar
• Ioachimescu OC, Ramos JA, Hoffman M, McCarthy K, Stoller JK. Assessing bronchodilator response by changes in per cent predicted forced expiratory volume in one second. J Investig Med. 2021;69(5):1027–1034. doi:10.1136/jim-2020-001663
   PubMed Web of Science ®Google Scholar
• Hansen JE, Dilektasli AG, Porszasz J, et al. A new bronchodilator response grading strategy identifies distinct patient populations. Ann Am Thorac Soc. 2019;16(12):1504–1517. doi:10.1513/AnnalsATS.201901-030OC
   PubMed Web of Science ®Google Scholar
• Dandurand RJ, Lavoie J-P, Lands LC, Hantos Z. Comparison of oscillometry devices using active mechanical test loads. ERJ Open Res. 2019;5(4):00160–2019. doi:10.1183/23120541.00160-2019
   PubMedGoogle Scholar
• Fabbri LM, Romagnoli M, Corbetta L, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167(3):418–424. doi:10.1164/rccm.200203-183OC
   PubMed Web of Science ®Google Scholar
• Jiang D, Wang Z, Shen C, et al. Small airway dysfunction may be an indicator of early asthma: findings from high-resolution CT. Ann Allerg Asthma Immunol. 2019;122(5):498–501. doi:10.1016/j.anai.2019.02.024
   PubMed Web of Science ®Google Scholar
• Suzuki S, Miyashita A, Matsumoto Y, Okubo T. Bronchoconstriction induced by spirometric maneuvers in patients with bronchial asthma. Ann Allergy. 1990;65(4):315–320.
   PubMedGoogle Scholar
• Froeb HF, Mead J. Relative hysteresis of the dead space and lung in vivo. J Appl Physiol. 1968;25(3):244–248. doi:10.1152/jappl.1968.25.3.244
   PubMed Web of Science ®Google Scholar
• Oostveen E, Boda K, van der Grinten CP, et al. Respiratory impedance in healthy subjects: baseline values and bronchodilator response. Multicenter study. Eur Respir J. 2013;42(6):1513–1523. doi:10.1183/09031936.00126212
   PubMed Web of Science ®Google Scholar
• Houghton CM, Woodcock AA, Singh D. A comparison of lung function methods for assessing dose-response effects of salbutamol. Br J Clin Pharmacol. 2004;58(2):134–141. doi:10.1111/j.1365-2125.2004.02105.x
   PubMed Web of Science ®Google Scholar
• Houghton CM, Woodcock AA, Singh D. A comparison of plethysmography, spirometry and oscillometry for assessing the pulmonary effects of inhaled ipratropium bromide in healthy subjects and patients with asthma. Br J Clin Pharmacol. 2005;59(2):152–159. doi:10.1111/j.1365-2125.2004.2262.x
   PubMed Web of Science ®Google Scholar
• Tommola M, Ilmarinen P, Tuomisto LE, et al. Differences between asthma–COPD overlap syndrome and adult-onset asthma. Eur Respir J. 2017;49(5):1602383. doi:10.1183/13993003.02383-2016
   PubMed Web of Science ®Google Scholar
• Ari A. Jet, ultrasonic, and mesh nebulizers: an evaluation of nebulizers for better clinical outcomes. Eur J Pulmonol. 2014;16:1–7. doi:10.5152/ejp.2014.00087
   Google Scholar
• Cavallazzi RS, Polivka BJ, Beatty BL, et al. Current bronchodilator responsiveness criteria underestimate asthma in older adults. Respir Care. 2020;65:1104–1111. doi:10.4187/respcare.07132
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar